Open AccessRemdesivir Research Progress: An Overview of the Emerging Evidence
Author(s) -
Aamir Al-Mosawi
Publication year - 2020
Publication title -
journal of biomedical research and environmental sciences
Language(s) - English
Resource type - Journals
ISSN - 2766-2276
DOI - 10.37871/jbres1146
Subject(s) - covid-19 , virology , coronavirus , betacoronavirus , medicine , biology , outbreak , pathology , infectious disease (medical specialty) , disease
There has been an increasing interest in remdesivir research within the scientific medical community because of the emerging evidence suggesting its beneficial role in patients with COVID‑19. Remdesivir which can be given intravenously and not orally has an anti-viral against several RNA viruses. Remdesivir has an in vitro antiviral activity against filoviruses, arenaviruses, and coronaviruses including circulating human coronaviruses HCoV-OC43, HCoV-229E, SARS, and MERS zoonotic coronaviruses.